Cellulitis and Abscess Management in the Era of Resistance to Antibiotics (CAMERA)

Table 5. Initial antibiotic therapy for those with an abscess

Antibiotic % (n)
Beta-Lactam/Cephalosporin 7% (36)
Beta-Lactam/Cephalosporin and Mupirocin 1% (4)
Beta-Lactam/Cephalosporin and Retapamulin <1% (1)
Beta-Lactam/Cephalosporin and Sulfonamide 5% (23)
Beta-Lactam/Cephalosporin, Sulfonamide, and Mupirocin 1% (5)
Clindamycin 8% (39)
Clindamycin and Mupirocin 2% (10)
Clindamycin and Tetracycline <1% (1)
Clindamycin, Mupirocin, and Sulfonamide 1% (3)
Docycycline <1% (2)
Docycycline and Fluorqouinalone <1% (1)
Doxycycline and Sulfonamide <1% (1)
Fluorqouinalone <1% (2)
Fluorqouinalone and Mupirocin <1% (1)
Fluorqouinalone and Tetracycline 1% (3)
Mupirocin 1% (6)
Sulfonamide 47% (232)
Sulfonamide and Clindamycin 1% (5)
Sulfonamide and Erythromycin <1% (1)
Sulfonamide and Fluorqouinalone <1% (2)
Sulfonamide and Metronidazole <1% (1)
Sulfonamide and Mupirocin 16% (80)
Sulfonamide and Retapamulin 1% (4)
Sulfonamide and Tetracycline <1% (2)
Sulfonomide and Mupirocin <1% (1)
Sulfonomide and Retapumulin <1% (1)
Tetracycline 1% (3)

Return to Document

Page last reviewed October 2014
Page originally created September 2012
Internet Citation: Table 5. Initial antibiotic therapy for those with an abscess. Content last reviewed October 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/mrsa/nc_mrsatab5.html